Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation

Poly (adenosine diphosphate-ribose) polymerase inhibitors (PARP)i are emerging as standard oncology treatments in various tumor types. The indications will expand as PARPi are being investigated in various breast cancer subtypes. Currently, except for BRCA1/2 mutation carriers with human epidermal g...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelariu-Raicu, Anca, Piha-Paul, Sarina A., Chavez-MacGregor, Mariana, Johnson, Jason, Sawaya, Raymond, McAleer, Mary Frances, Nguyen, Alissa, Hartnett, Audrey, Tsimberidou, Apostolia M., Meric-Bernstam, Funda, Dumbrava, Ecaterina E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448731/
https://www.ncbi.nlm.nih.gov/pubmed/37637237
http://dx.doi.org/10.36401/JIPO-22-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448731/
https://www.ncbi.nlm.nih.gov/pubmed/37637237
http://dx.doi.org/10.36401/JIPO-22-33

Ejemplares similares